leisure time -WSS

leisure time

author：fashion 2025-08-26 10:53:01 - browse：2865

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Akero's treatment for NASH falls short in cirrhosis study

WSS

FDA approves RSV monoclonal antibody for infants, toddlers

Biden tests positive for Covid

There’s no way to know how good AI health technologies are

Doctors find melanoma drugs effective against rare brain cancer

What's changing in Medicare's open enrollment this year?

Sanders adds drug shortage policies to pandemic preparedness bill

focus

leisure time

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

At Orexo, a ‘turning point’ for everything but digital health

Walensky prepares to leave CDC — and Congress — behind

Cancer cells are shown to suck energy source from immune cells

Duchenne breakthrough therapy leaves behind pioneering families

Female surgeons have lower rates of long

State Dept. review finds Biden bears some blame for Afghanistan failures

How clinical AI models' predictive power can degrade over time

Peter Hotez and the public health issue of online harassment

There’s no way to know how good AI health technologies are

hotspot

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

A revolution in caring for preterm infants

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

How should state employee insurance handle Wegovy?

Eight reasons why you should get an updated Covid vaccine

Google and Epic fight stronger regulation of AI in health care

hotspot

focus

Wikipedia

focus